Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 2/20 | 0.54 |
| ▸ | RARG | P13631 | 2/20 | 0.54 |
| ▸ | RARA | P10276 | 1/20 | 0.54 |
| ▸ | RXRA | P19793 | 1/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.43 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18084341 | 1.00 | RARB (0.54) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL16670830 | 0.89 | RARB (0.56) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL13554229 | 0.89 | RARB (0.56) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL24475285 | 0.87 | RARB (0.58) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL18084306 | 0.87 | RARB (0.51) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL703376 | 0.86 | RARB (0.60) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL703377 | 0.86 | RARB (0.60) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL9202781 | 0.86 | RARB (0.60) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL16671579 | 0.85 | RARB (0.49) | RARBRARGRARARXRATRPA1 | |
| SCHEMBL21369152 | 0.84 | RARB (0.51) | RARBRARGRARARXRATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858948-B2 | Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes | FIRMENICH SA (CH) | 2024-01-02 | — | — | US | disclosed |
| US-11858948-B2 | Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes | FIRMENICH SA (CH) | 2024-01-02 | — | — | US | disclosed |
| US-11858948-B2 | Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes | FIRMENICH SA (CH) | 2024-01-02 | — | — | US | disclosed |
| EP-3700914-B1 | HYDROGENATION OF CARBONYLS WITH TETRADENTATE PNNP LIGAND RUTHENIUM COMPLEXES | FIRMENICH & CIE (CH) | 2022-02-02 | — | — | EP | disclosed |
| EP-3700914-B1 | HYDROGENATION OF CARBONYLS WITH TETRADENTATE PNNP LIGAND RUTHENIUM COMPLEXES | FIRMENICH & CIE (CH) | 2022-02-02 | — | — | EP | disclosed |
| EP-3268346-B1 | PROCESSES FOR THE PREPARATION OF UNSATURATED MALONATES | INT FLAVORS & FRAGRANCES INC (US) | 2021-05-05 | — | — | EP | disclosed |
| US-20200399299-A1 | HYDROGENATION OF CARBONYLS WITH TETRADENTATE PNNP LIGAND RUTHENIUM COMPLEXES | FIRMENICH SA (CH) | 2020-12-24 | — | — | US | disclosed |
| WO-2019175158-A1 | HYDROGENATION OF CARBONYLS WITH TETRADENTATE PNNP LIGAND RUTHENIUM COMPLEXES | FIRMENICH SA (CH) | 2019-09-19 | — | — | WO | disclosed |
| US-10358415-B2 | Processes for the preparation of unsaturated malonates | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2019-07-23 | — | — | US | disclosed |
| US-10081613-B2 | 2-(alkoxy or aryloxy carbonyl)-4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hex-2-enoic acid compounds, its preparation and use | Givaudan, S.A. (CH) | 2018-09-25 | — | — | US | disclosed |
| US-8933253-B2 | 2-(Alkoxy or aryloxy carbonyl)-4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hex-2-enoic acid compunds, its preparation and use | GIVAUDAN S.A. (CH) | 2015-01-13 | — | — | US | disclosed |
| US-20140275578-A1 | 2-(ALKOXY OR ARYLOXY CARBONYL)-4-METHYL-6-(2,6,6-TRIMETHYLCYCLOHEX-1- ENYL)HEX-2-ENOIC ACID COMPOUNDS, ITS PREPARATION AND USE | GIVAUDAN S.A. (CH) | 2014-09-18 | — | — | US | disclosed |
| US-20140275578-A1 | 2-(ALKOXY OR ARYLOXY CARBONYL)-4-METHYL-6-(2,6,6-TRIMETHYLCYCLOHEX-1- ENYL)HEX-2-ENOIC ACID COMPOUNDS, ITS PREPARATION AND USE | GIVAUDAN S.A. (CH) | 2014-09-18 | — | — | US | disclosed |
| US-8765980-B2 | Organic compounds | GIVAUDAN S.A. (CH) | 2014-07-01 | — | — | US | disclosed |
| US-8765980-B2 | Organic compounds | GIVAUDAN S.A. (CH) | 2014-07-01 | — | — | US | disclosed |
| US-20120271059-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2012-10-25 | — | — | US | disclosed |
| WO-2012085056-A1 | 2-(ALKOXY OR ARYLOXY CARBONYL)-4-METHYL-6-(2,6,6-TRIMETHYLCYCLOHEX-1-ENYL)HEX-2-ENOIC ACID COMPOUNDS, ITS PREPARATION AND USE | GIVAUDAN SA (CH) | 2012-06-28 | — | — | WO | disclosed |
| WO-2011073387-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2011-06-23 | — | — | WO | disclosed |
| US-7683190-B2 | Process for the preparation of optically-active compounds | GIVAUDAN SA (CH) | 2010-03-23 | — | — | US | disclosed |
| US-20080064886-A1 | Process for the Preparation of Optically-Active Compounds | GIVAUDAN SA (CH) | 2008-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10358415-B2 | Processes for the preparation of unsaturated malonates | ME1, ACSL6, MAL2 | RARB 87/4885RARG 92/4885RARA 34/4885 |
| US-20120271059-A1 | Organic Compounds | HSD17B12, HSD17B1, MAL2 | RARB 408/4885RARG 568/4885RARA 530/4885 |
| US-10081613-B2 | 2-(alkoxy or aryloxy carbonyl)-4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hex-2-enoic acid compounds, its preparation and use | HRH2, HRH1, ENY2 | RARB 432/4885RARG 574/4885RARA 311/4885 |
| US-11858948-B2 | Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes | ADH1C, ADH1A, ADH5 | RARB 2983/4885RARG 2648/4885RARA 3378/4885 |
| US-20080064886-A1 | Process for the Preparation of Optically-Active Compounds | ADH1C, ADH1A, CYP2E1 | RARB 206/4885RARG 329/4885RARA 174/4885 |
| US-20140275578-A1 | 2-(ALKOXY OR ARYLOXY CARBONYL)-4-METHYL-6-(2,6,6-TRIMETHYLCYCLOHEX-1- ENYL)HEX-2-ENOIC ACID COMPOUNDS, ITS PREPARATION AND USE | HRH2, HRH1, ENY2 | RARB 374/4885RARG 516/4885RARA 244/4885 |
| US-20200399299-A1 | HYDROGENATION OF CARBONYLS WITH TETRADENTATE PNNP LIGAND RUTHENIUM COMPLEXES | ADH1C, ADH1A, ADH5 | RARB 2983/4885RARG 2648/4885RARA 3378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.